Position in NTRA
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$5,290,017
+$2,351,964 QoQ
Shares Held
19,488
+32.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#259
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026QRG CAPITAL MANAGEMENT, INC. holds $62,814,130 across 17 Diagnostics & Research names. NTRA ranks #6 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
36,743 | $18,421,470 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
58,407 | $11,285,400 | |
| 3 | DHR |
Danaher Corp /De/
|
36,461 | $6,945,091 | |
| 4 | A |
Agilent Technologies, Inc.
|
49,576 | $6,585,180 | |
| 5 | DGX |
Quest Diagnostics Inc
|
25,798 | $5,467,886 | |
| 6 | NTRA |
Natera, Inc.
This page
|
19,488 | $5,290,017 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
3,323 | $1,749,360 | |
| 8 | ILMN |
Illumina, Inc.
|
7,261 | $1,276,701 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,290,017 | 19,488 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,938,053 | 14,691 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,865,228 | 12,507 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $748,832 | 4,652 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,175,991 | 6,961 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $766,017 | 5,417 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $844,688 | 5,336 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $670,549 | 5,282 | Shares | Sole | 2024-10-30 | |
| No filing history on record for this holder in this stock. | ||||||